Published in the journal Gastrointestinal Endoscopy, the data include a mean total weight loss of 14.8%±8.5% at 18 months. Three months following surgery, the impact on obesity-related comorbidities included the complete remission of:
- 13 of 17 cases of type 2 diabetes.
- All 28 cases of hypertension.
- 18 of 32 cases of dyslipidemia.
The post Apollo Endosurgery touts results of stomach-stapling study appeared first on MassDevice.